Publication Information

{'id': 'https://openalex.org/W1997856719', 'doi': 'https://doi.org/10.1007/s40121-014-0052-8', 'title': 'In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir', 'display_name': 'In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir', 'publication_year': 2014, 'publication_date': '2014-12-16', 'ids': {'openalex': 'https://openalex.org/W1997856719', 'doi': 'https://doi.org/10.1007/s40121-014-0052-8', 'mag': '1997856719', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/25516102', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4363215'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s40121-014-0052-8', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007/s40121-014-0052-8.pdf', 'source': {'id': 'https://openalex.org/S2739130986', 'display_name': 'Infectious Diseases and Therapy', 'issn_l': '2193-6382', 'issn': ['2193-6382', '2193-8229'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320330', 'host_organization_name': 'Adis, Springer Healthcare', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310320330'], 'host_organization_lineage_names': ['Springer Nature', 'Adis, Springer Healthcare'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://link.springer.com/content/pdf/10.1007/s40121-014-0052-8.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5031228088', 'display_name': 'Jacques Friborg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Jacques Friborg', 'raw_affiliation_strings': ['Bristol–Myers Squibb, Research and Development,Wallingford,USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol–Myers Squibb, Research and Development,Wallingford,USA', 'institution_ids': ['https://openalex.org/I157075465']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082613080', 'display_name': 'Nannan Zhou', 'orcid': 'https://orcid.org/0000-0001-9085-4373'}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Nannan Zhou', 'raw_affiliation_strings': ['Bristol–Myers Squibb, Research and Development,Wallingford,USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol–Myers Squibb, Research and Development,Wallingford,USA', 'institution_ids': ['https://openalex.org/I157075465']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091515210', 'display_name': 'Zhou Han', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Zhou Han', 'raw_affiliation_strings': ['Bristol–Myers Squibb, Research and Development,Wallingford,USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol–Myers Squibb, Research and Development,Wallingford,USA', 'institution_ids': ['https://openalex.org/I157075465']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101424015', 'display_name': 'Xiaoyan Yang', 'orcid': 'https://orcid.org/0000-0003-3483-5658'}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Xiaoyan Yang', 'raw_affiliation_strings': ['Bristol–Myers Squibb, Research and Development,Wallingford,USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol–Myers Squibb, Research and Development,Wallingford,USA', 'institution_ids': ['https://openalex.org/I157075465']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017508144', 'display_name': 'Paul Falk', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Paul Falk', 'raw_affiliation_strings': ['Bristol–Myers Squibb, Research and Development,Wallingford,USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol–Myers Squibb, Research and Development,Wallingford,USA', 'institution_ids': ['https://openalex.org/I157075465']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053398145', 'display_name': 'Patricia Méndez', 'orcid': 'https://orcid.org/0000-0001-5283-307X'}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Patricia Mendez', 'raw_affiliation_strings': ['Bristol Myers-Squibb Research and Development, Lawrenceville, USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers-Squibb Research and Development, Lawrenceville, USA', 'institution_ids': ['https://openalex.org/I157075465']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5087714251', 'display_name': 'Fiona McPhee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Fiona McPhee', 'raw_affiliation_strings': ['Bristol–Myers Squibb, Research and Development,Wallingford,USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol–Myers Squibb, Research and Development,Wallingford,USA', 'institution_ids': ['https://openalex.org/I157075465']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4700, 'currency': 'GBP', 'value_usd': 6850, 'provenance': 'doaj'}, 'apc_paid': {'value': 4700, 'currency': 'GBP', 'value_usd': 6850, 'provenance': 'doaj'}, 'fwci': 3.036, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 26, 'citation_normalized_percentile': {'value': 0.739219, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '4', 'issue': '1', 'first_page': '137', 'last_page': '144'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9899, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9723, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/daclatasvir', 'display_name': 'Daclatasvir', 'score': 0.99882084}, {'id': 'https://openalex.org/keywords/sofosbuvir', 'display_name': 'Sofosbuvir', 'score': 0.88303185}, {'id': 'https://openalex.org/keywords/ns5a', 'display_name': 'NS5A', 'score': 0.801072}, {'id': 'https://openalex.org/keywords/simeprevir', 'display_name': 'Simeprevir', 'score': 0.5902059}, {'id': 'https://openalex.org/keywords/ns3', 'display_name': 'NS3', 'score': 0.5734687}, {'id': 'https://openalex.org/keywords/ledipasvir', 'display_name': 'Ledipasvir', 'score': 0.4515738}], 'concepts': [{'id': 'https://openalex.org/C2776979040', 'wikidata': 'https://www.wikidata.org/wiki/Q5207712', 'display_name': 'Daclatasvir', 'level': 5, 'score': 0.99882084}, {'id': 'https://openalex.org/C2778390639', 'wikidata': 'https://www.wikidata.org/wiki/Q2502747', 'display_name': 'Sofosbuvir', 'level': 5, 'score': 0.88303185}, {'id': 'https://openalex.org/C2777103181', 'wikidata': 'https://www.wikidata.org/wiki/Q83141840', 'display_name': 'NS5A', 'level': 5, 'score': 0.801072}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7087877}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.60665935}, {'id': 'https://openalex.org/C2776408679', 'wikidata': 'https://www.wikidata.org/wiki/Q708693', 'display_name': 'Hepatitis C virus', 'level': 3, 'score': 0.5970762}, {'id': 'https://openalex.org/C2778986448', 'wikidata': 'https://www.wikidata.org/wiki/Q7517689', 'display_name': 'Simeprevir', 'level': 5, 'score': 0.5902059}, {'id': 'https://openalex.org/C132379496', 'wikidata': 'https://www.wikidata.org/wiki/Q83141645', 'display_name': 'NS3', 'level': 4, 'score': 0.5734687}, {'id': 'https://openalex.org/C2775999097', 'wikidata': 'https://www.wikidata.org/wiki/Q15409409', 'display_name': 'Ledipasvir', 'level': 5, 'score': 0.4515738}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.35086197}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34793103}, {'id': 'https://openalex.org/C2780040827', 'wikidata': 'https://www.wikidata.org/wiki/Q421862', 'display_name': 'Ribavirin', 'level': 4, 'score': 0.23938581}, {'id': 'https://openalex.org/C2781463415', 'wikidata': 'https://www.wikidata.org/wiki/Q2082778', 'display_name': 'Hepacivirus', 'level': 4, 'score': 0.2144388}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.16678974}], 'mesh': [], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s40121-014-0052-8', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007/s40121-014-0052-8.pdf', 'source': {'id': 'https://openalex.org/S2739130986', 'display_name': 'Infectious Diseases and Therapy', 'issn_l': '2193-6382', 'issn': ['2193-6382', '2193-8229'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320330', 'host_organization_name': 'Adis, Springer Healthcare', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310320330'], 'host_organization_lineage_names': ['Springer Nature', 'Adis, Springer Healthcare'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4363215', 'pdf_url': 'https://europepmc.org/articles/pmc4363215?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363215', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/25516102', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s40121-014-0052-8', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007/s40121-014-0052-8.pdf', 'source': {'id': 'https://openalex.org/S2739130986', 'display_name': 'Infectious Diseases and Therapy', 'issn_l': '2193-6382', 'issn': ['2193-6382', '2193-8229'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320330', 'host_organization_name': 'Adis, Springer Healthcare', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310320330'], 'host_organization_lineage_names': ['Springer Nature', 'Adis, Springer Healthcare'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.8, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 23, 'referenced_works': ['https://openalex.org/W1551301313', 'https://openalex.org/W1963623224', 'https://openalex.org/W1980771473', 'https://openalex.org/W1987935503', 'https://openalex.org/W2002608073', 'https://openalex.org/W2026065136', 'https://openalex.org/W2054768505', 'https://openalex.org/W2064285218', 'https://openalex.org/W2071505878', 'https://openalex.org/W2106081736', 'https://openalex.org/W2117944708', 'https://openalex.org/W2124085267', 'https://openalex.org/W2125958583', 'https://openalex.org/W2126626331', 'https://openalex.org/W2127189337', 'https://openalex.org/W2127621015', 'https://openalex.org/W2147822795', 'https://openalex.org/W2147940657', 'https://openalex.org/W2148840656', 'https://openalex.org/W2151554611', 'https://openalex.org/W2164991452', 'https://openalex.org/W2166962970', 'https://openalex.org/W2330057588'], 'related_works': ['https://openalex.org/W4235735086', 'https://openalex.org/W2990928766', 'https://openalex.org/W2895317053', 'https://openalex.org/W2753462031', 'https://openalex.org/W2264049562', 'https://openalex.org/W2216962669', 'https://openalex.org/W2047911275', 'https://openalex.org/W1990772217', 'https://openalex.org/W1952164093', 'https://openalex.org/W1605911101'], 'abstract_inverted_index': {'Daclatasvir': [0], 'is': [1, 21], 'a': [2, 22, 80, 119, 151, 207, 220], 'non-structural': [3, 23], 'protein': [4, 24], '5A': [5], '(NS5A)': [6], 'inhibitor': [7, 28, 156], 'with': [8, 29, 56, 82, 226], 'activity': [9, 30, 62, 159], 'against': [10, 31], 'hepatitis': [11], 'C': [12], 'virus': [13], '(HCV)': [14], 'genotypes': [15, 32], '1–6': [16], 'in': [17, 67, 111, 118, 160, 203, 235], 'vitro,': [18], 'and': [19, 36, 85, 94, 113, 133, 147, 162, 181], 'asunaprevir': [20, 95, 177, 184], '3': [25], '(NS3)': [26], 'protease': [27], '1,': [33], '4,': [34], '5,': [35], '6.': [37], 'This': [38], 'study': [39], 'evaluates': [40], 'potential': [41, 210], 'options': [42, 213], 'for': [43, 214], 'the': [44], 're-treatment': [45], 'of': [46, 63, 128, 137, 174, 200, 209], 'HCV': [47, 68], 'genotype': [48, 74], '1b-infected': [49], 'patients': [50, 215], 'who': [51, 216], 'have': [52], 'failed': [53], 'combination': [54, 65, 172], 'therapy': [55, 225], 'daclatasvir': [57, 93, 138, 175, 182, 191, 227], 'plus': [58, 139, 142, 145, 149, 176, 178, 183, 185, 187, 228], 'asunaprevir.': [59, 229], 'The': [60], 'antiviral': [61], 'drug': [64, 130, 169], 'regimens': [66, 173], 'subgenomic': [69], 'replicon': [70, 99], 'cell': [71, 164], 'lines': [72], 'representing': [73, 104], '1b': [75], '(Con1': [76], 'strain)': [77], 'wild-type': [78, 161], 'or': [79, 154], 'variant': [81], 'specific': [83], 'NS5A': [84, 155], 'NS3': [86, 153], 'amino': [87], 'acid': [88], 'substitutions': [89], 'conferring': [90], 'resistance': [91], 'to': [92], 'were': [96, 122], 'compared': [97], 'using': [98], 'elimination': [100], 'assays.': [101], 'Drug': [102], 'concentrations': [103, 108, 116], 'multiple': [105, 125], '50%': [106], 'effective': [107], '(EC50)': [109], 'derived': [110], 'vitro': [112, 204], 'trough': [114, 170], 'plasma': [115], 'observed': [117], 'clinical': [120, 236], 'setting': [121], 'utilized.': [123], 'At': [124, 166], 'EC50': [126], 'values': [127], 'each': [129], '(3×,': [131], '10×,': [132], '30×': [134], 'EC50),': [135], 'combinations': [136], 'sofosbuvir,': [140], 'sofosbuvir': [141, 144, 148, 188], 'ledipasvir,': [143], 'simeprevir,': [146], 'either': [150], 'next-generation': [152], 'demonstrated': [157], 'comparable': [158], 'daclatasvir/asunaprevir-resistant': [163], 'lines.': [165], 'clinically': [167], 'relevant': [168], 'concentrations,': [171], 'beclabuvir': [179, 186], '(±ribavirin),': [180], 'efficiently': [189], 'cleared': [190], '+': [192], 'asunaprevir-resistant': [193], 'replicons': [194], 'from': [195], 'cells': [196], 'within': [197], '5': [198], 'days': [199], 'treatment.': [201], 'Our': [202], 'results': [205, 231], 'highlight': [206], 'number': [208], 'all-oral': [211], 'treatment': [212], 'do': [217], 'not': [218], 'achieve': [219], 'sustained': [221], 'virologic': [222], 'response': [223], 'following': [224], 'These': [230], 'require': [232], 'further': [233], 'evaluation': [234], 'studies.': [237]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1997856719', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 7}, {'year': 2016, 'cited_by_count': 7}, {'year': 2015, 'cited_by_count': 5}], 'updated_date': '2024-12-07T17:09:47.725939', 'created_date': '2016-06-24'}